PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 10, 2026Alzheimer s & Dementia4 citations

Resistance training and subcortical vascular cognitive impairment: A 12‐month randomized trial

View Full Paper
TLTeresa Liu‐AmbroseRFRyan S. FalckEDElizabeth Dao

Key Points

  • To determine if progressive resistance training enhances cognitive function in adults with subcortical vascular cognitive impairment.
  • 12-month randomized trial
  • Participants randomized to progressive resistance training or balance and tone exercises
  • Measured cognitive function using the ADAS-Cog-Plus scale
  • Progressive resistance training improved ADAS-Cog-Plus scores significantly with a mean difference of −0.18 (p = 0.04).
  • Significant improvements for females with a mean difference of −0.27 (p = 0.02).
  • PRT also reduced C-reactive protein by −2.93 (p = 0.02).

Abstract

Abstract INTRODUCTION It is unknown whether progressive resistance training (PRT) improves cognitive function in adults with cerebral small vessel disease and mild cognitive impairment (i.e., subcortical vascular cognitive impairment SVCI). METHODS We conducted a 12‐month randomized trial comparing PRT versus balance and tone exercises (BAT) on the Alzheimer's Disease Assessment Scale Cognitive Plus (ADAS‐Cog‐Plus). RESULTS Ninety‐one participants were randomized (PRT = 45; BAT = 46); 76 completed the trial. Adherence was not different between groups ( p = 0.18). At 12 months, PRT significantly improved ADAS‐Cog‐Plus scores (estimated mean difference: −0.18; 95% confidence interval CI: −0.35, −0.01; p = 0.04). Planned contrasts stratified by sex showed a significant PRT effect on ADAS‐Cog‐Plus scores for females (mean difference: −0.27; 95% CI: −0.49, −0.05; p = 0.02), but not for males. PRT also significantly reduced C‐reactive protein (estimated mean difference: −2.93; 95% CI: −5.36, −0.49; p = 0.02). No significant differences were observed for other secondary outcomes. DISCUSSION PRT may have a small beneficial effect on cognitive function in SVCI. CLINICAL TRIAL REGISTRATION This trial was registered with ClinicalTrials.gov (NCT02669394).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liu‐Ambrose et al. (2026) studied this question.

synapsesocial.com/papers/69af952b70916d39fea4c670https://doi.org/10.1002/alz.71245
Ask AI
Helpful
Bookmark
Share
View Full Paper